RNU6-107P

Across TCGA pan-cancer cohorts, RNU6-107P RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of RNU6-107P’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where RNU6-107P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RNU6-107P is over-expressed in tumor, although a few such as LUAD show the opposite, repressed pattern.

KIRC, COAD, and LUAD are the cancer types where RNU6-107P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RNU6-107P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Male	All	+0.132	.016	3	view →
COAD	Male	II,III,IV	+0.248	.019	2	view →
LUAD	All	III,IV	−0.272	.034	1	view →
KICH	All	II,III,IV	+0.155	.041	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

RNU6-107P–KIRC

Open the KIRC breakdown →